Role of Toll-Like Receptor 4 in Induction of Cell-Mediated Immunity and Resistance to Brucella abortus Infection in Mice

Infection and Immunity

Volumn 72, Issue 1, 2004, Pages 176-186

  Campos, Marco A ^a,b   Rosinha, Gracia M S ^a,c   Almeida, Igor C ^d   Salgueiro, Xirlene S ^d   Jarvis, Bruce W ^e   Splitter, Gary A ^e   Qureshi, Nilofer ^f   Bruna Romero, Oscar ^b   Gazzinelli, Ricardo T ^a,b   Oliveira, Sergio C ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c EMBRAPA CERRADOS   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; LIPID A; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BRUCELLA ABORTUS; BRUCELLOSIS; CELL ACTIVATION; CELL MATURATION; CELLULAR IMMUNITY; CHO CELL; CLEARANCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE EXACERBATION; FLOW CYTOMETRY; GENETIC TRANSFECTION; HOST RESISTANCE; KNOCKOUT MOUSE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHODOBACTER SPHAEROIDES; SIGNAL TRANSDUCTION;

ANIMALS; BRUCELLA ABORTUS; BRUCELLOSIS; CHO CELLS; CRICETINAE; DENDRITIC CELLS; FLOW CYTOMETRY; IMMUNITY, CELLULAR; LIPID A; LIPOPOLYSACCHARIDES; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; SPLEEN; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 9144228704     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.1.176-186.2004     Document Type: Article

References (62)

1. Abel, B., N. Thieblemont, V. J. F. Quesniaux, N. Brown, J. Mpagi, K. Miyake, F. Bihl, and B. Ryffel. 2002. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J. Immunol. 169:3155-3162.
2. Aliprantis, A. O., R.-B. Yang, M. R. Mark, S. Suggett, B. Devaux, J. D. Radolf, G. R. Klimpel, P. Godowski, and A. Zychlinsky. 1999. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 285:736-739.
3. Allen, C. A., L. Garry Adams, and T. A. Ficht. 1998. Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival. Infect. Immun. 66:1008-1016.
4. Araya, L. N., and A. J. Winter. 1990. Comparative protection of mice against virulent and attenuated strains of Brucella abortus by passive transfer of immune T cells and serum. Infect. Immun. 58:254-256.
5. Brightbill, H. D., D. H. Libraty, S. R. Krutzik, R.-B. Yang, J. T. Belisle, J. R. Bleharski, M. Maitland, M. V. Norgard, S. E. Plevy, S. T. Smale, P. J. Brennan, B. R. Bloom, P. J. Godowski, and R. L. Modlin. 1999. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 285:732-736.
6. Brinley Morgan, W. J., and M. J. Corbel. 1990. Brucella infections in man and animals: contagious equine metritis, p. 547-585. In M. T. Parker and L. H. Collier (ed.) Topley and wilson's principles of bacteriology, virology and immunology. Edward Arnold, London, UK.
7. Bruna-Romero, O., and A. Rodriguez. 2001. Dendritic cells can initiate protective immune responses against malaria. Infect. Immun. 69:5173-5176.
8. Camargo, M. M., I. C. Almeida, M. E. S. Pereira, M. A. J. Ferguson, L. R. Travassos, and R. T. Gazzinelli. 1997. GPI-anchored mucin-like glycoprotein isolated from Trypanosoma cruzi initiate the synthesis of proinflammatory cytokines by macrophages. J. Immunol. 158:5890-5901.
9. Campos, M. A. S., I. C. Almeida, O. Takeuchi, et al. 2001. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol. 167:416-423.
10. Delude, R. L., A. Yoshimura, R. R. Ingalls, and D. T. Golenbock. 1998. Construction of a lipopolysaccharide reporter cell line and its use in identifying mutants defective in endotoxin, but not TNF-α, signal transduction. J. Immunol. 161:3001-3009.
11. Erridge, C., E. Bennett-Guerrero, and I. R. Poxton. 2002. Structure and function of lipopolysaccharides. Microbes Infect. 4:837-851.
12. Folch, J., M. Lees, and G. H. S Stanley. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:497-504.
13. Forestier, C., F. Deleuil, N. Lapaque, E. Moreno, and J. Gorvel. 2000. Brucella abortus lipopolysaccharide in murine peritoneal macrophages acts as a down-regulator of T-cell activation. J. Immunol. 165:5202-5210.
14. Galanos, C., O. Luderitz, E. T. Rietschel, O. Westphal, H. Brade, L. Brade, M. Freundenberg, U. Schade, M. Imoto, and H. Yoshimura. 1985. Synthetic and natural E. coli free lipid A express identical entotoxic activities. Eur. J. Biochem. 148:1-5.
15. Golding, B., N. Eller, L. Levy, P. Beining, J. Inman, N. Matthews, D. E. Scott, and H. Golding. 2002. Mucosal immunity in mice immunized with HIV-1 peptide conjugated to Brucella abortus. Vaccine 20:1445-1450.
16. Goldstein, J., T. Hoffman, C. Frasch, E. F. Lizzio, P. R. Beining, D. Hochstein, Y. L. Lee, R. D. Angus, and B. Golding. 1992. Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus and LPS from B. abortus as a carrier vaccines. Infect. Immun. 60:1385-1389.
17. Hailman, E., H. S. Lichenstein, M. M. Wurfel, D. S. Miller, D. A. Johnson, M. Kelley, L. A. Busse, M. M. Zukowski, and S. D. Wright. 1994. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J. Exp. Med. 179:269-277.
18. Henneke, P., O. Takeuchi, J. A. Strijp, H-K Guttormsen, J. A. Smith, A. B. Schromm, T. A. Espevik, S. Akira, V. Nizet, D. L. Kasper, and D. T. Golenbock. 2001. Novel engagement of CD14 and multiple Toll-like receptors by group B Streptococci. J. Immunol. 167:7069-7076.
19. Hirschfeld, M., C. J. Kirschning, R. Schwandner, H. Wesche, J. H. Weis, R. M. Wooten, and J. J. Weis. 1999. Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by Toll-like receptor 2. J. Immunol. 163:2382-2386.
20. Hirschfeld, M., J. J. Weis, V. Toshchakov, C. A. Salkowski, M. J. Cody, D. C. Ward, N. Qureshi, S. M. Michalek, and S. N. Vogel. 2001. Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immun. 69:1477-1482.
21. Hirschfeld, M., Y. Ma, J. H. Weis, S. N. Vogel, and J. J. Weis. 2000. Repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J. Immunol. 165:618-622.
22. Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira. 1999. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:3749-3752.
23. Jarvis, B. W., and N. Qureshi. 1997. Inhibition of lipopolysaccharide-induced transcription factor Sp1 binding by spectrally pure diphosphoryl lipid A from Rhodobacter sphaeroides, protein kinase inhibitor H-8, and dexamethasone. Infect. Immun. 65:1640-1643.
24. Jarvis, B. W., H. Lichenstein, and N. Qureshi. 1997. Diphosphoryl lipid A from Rhodobacter sphaeroides inhibits complexes that form in vitro between lipopolysaccharide (LPS)-binding protein, soluble CD14, and spectrally pure LPS. Infect. Immun. 65:3011-3016.
25. Jiang, Q., S. Akashi, K. Miyake, and H. R. Petty. 2000. Lipopolysaccharide induces physical proximity between CD14 and Toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-κB J. Immunol. 165:3541-3544.
26. Ko, J., A. Gendron-Fitzpatrick, and G. A. Splitter. 2002. Susceptibility of IFN Regulatory Factor-1 and consensus sequence binding protein-deficent mice to brucellosis. J. Immunol. 168:2433-2440.
27. Kopp, E. B., and R. Medzhitov. 1999. The Toll-receptor family and control of innate immunity. Curr. Opin. Immunol. 11:13-18.
28. Liautard, J. P., A. Gross, J. Dornand, and S. Kohler. 1996. Interactions between professional phagocytes and Brucella spp. Microbiologia 12:197-206.
29. Lien, E., T. J. Sellati, A. Yoshimura, T. H. Flo, G. Rawadi, R. W. Finberg, J. D. Carroll, T. Espevik, R. R. Ingalls, J. D. Radolf, and D. T. Golenbock. 1999. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274:33419-33425.
30. Lien, E., T. K. Means, H. Heine, A. Yoshimura, S. Kusumoto, K. Fukase, M. Fenton, M. Oikawa, N. Qureshi, B. Monks, R. W. Finberg, R. R. Ingalls, and D. T. Golenbock. 2000. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Investig. 105:497-504.
31. Lorenz, E., D. D. Patel, T. Hartung, and D. A. Schwartz. 2002. Toll-like receptor 4 (TLR4)-deficient murine macrophage cell line as an in vitro assay system to show TLR4-independent signaling of Bacteroides fragilis lipopolysaccharide. Infect. Immun. 70:4892-4896.
32. Means, T. K., S. Wang, E. Lien, A. Yoshimura, D. T. Golenbock, and M. J. Fenton. 1999. Hum. Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol. 163:3920-3927.
33. Medzhitov, R., Jr., and C. A. Janeway. 1997. Innate immunity: the virtues of a monoclonal system of recognition. Cell 91:295-298.
34. Medzhitov, R., P. Preston-Hurburt, Jr., and C. A. Janeway. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394-397.
35. Moreno, E., M. W. Pitt, L. M. Jones, G. G. Schurig, and D. T. Berman. 1979. Purification and characterization of smooth and rough lipopolysaccharides from Brucella abortus. J. Bacteriol. 138:361-369.
36. Moriyon, I., and I. Lopez-Goni. 1998. Structure and properties of the outer membranes of Brucella abortus and Brucella melitensis. Int. Microbiol. 1:19-26.
37. Morrison, D. C., and J. L. Ryan. 1987. Endotoxins and disease mechanisms. Annu. Rev. Med. 38:417-432.
38. Murphy, E. A., M. Parent, J. Sathiyaseelan, X. Jiang, and C. L. Baldwin. 2001. Immune control of Brucella abortus 2308 infections in BALB/c mice. FEMS Immunol. Med. Microbiol. 32:85-88.
39. Murphy, E. A., J. Sathiyaseelan, M. Parent, B. Zou, and C. L. Baldwin. 2001. Interferon-γ is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. 2001. Immunology 103:511-518.
40. lo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class-I and class II-deficient mice. Eur. J. Immunol. 25:2551-2557.
41. Perera, P. Y., T. N. Mayadas, O. Takeuchi, S. Akira, M. Zaks-Zilberman, S. M. Goyert, and S. N. Vogel. 2001. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J. Immunol. 166:574-581.
42. Qureshi, N., J. Hofman, K. Takayama, S. N. Vogel, and D. C. Morrison. 1996. Diphosphoryl lipid A from Rhodobacter sphaeroides, a novel lipopolysaccharide antagonist. In D. C. Morrison and R. L. Ryan (ed.), Novel therapeutic strategies in the treatment of sepsis. Marcel Dekker, Inc., New York, N.Y.
43. Qureshi, N., J. P. Honovich, H. Hara, R. J. Cotter, and K. Takayama. 1988. Location of fatty acids in lipid A obtained from lipopolysaccharide of Rhodopseudomonas sphaeroides ATCC 17023. J. Biol. Chem. 263:5502-5504.
44. Qureshi, N., K. Takayama, U. Seydel, R. Wang, R. J. Cotter, P. K. Agrawal, C. A. Bush, R. Kurtz, and D. T. Berman. 1994. Structural analysis of the lipid A derived from the lipopolysaccharide of Brucella abortus. J. Endotox. Res. 1:137-148.
45. Rock, F. L., G. Hardiman, J. C. Timans, R. A. Kastelein, and J. F. Bazan. 1998. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. 95:588-593.
46. Rosinha, G. M. S., D. A. Freitas, A. Miyoshi, V. Azevedo, E. Campos, S. L. Cravero, O. Rossetti, G. Splitter, and S. C. Oliveira. 2002. Identification and characterization of a Brucella abortus ATP-binding cassette transporter homolog to Rhizobium meliloti ExsA and its role in virulence and protection in mice. Infect. Immun. 70:5036-5044.
47. Sangari, F. J., and J. Aguero. 1996. Molecular basis of Brucella pathogenicity: an update. Microbiologia 12:207-218.
48. Schwandler, R., R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem. 274:17406-17409.
49. Stevens, M. G., S. C. Olsen, G. W. Pugh, Jr., and D. Brees. 1995. Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 and RB51. Infect. Immun. 63:264-270.
50. Takeuchi, O., K. Hoshino, and S. Akira. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165:5392-5396.
51. Takeuchi, O., T. Kawai, H. Sanjo, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, K. Takeda, and S. Akira. 1999. TLR6: a novel member of an expanding Toll-like receptor family. Gene 231:59-65.
52. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takahada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of gram negative and gram-positive bacterial cell wall components. Immunity 11:443-451.
53. Underhill, D. M., A. H. Ozinsky, M. Adeline, A. Stevens, C. B. Wilson, M. Basseti, and A. Aderem. 1999. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401:811-815.
54. Vasselon, T., and P. A. Detmers. 2002. Toll receptors: a central element in innate immune responses. Infect. Immun. 70:1033-1041.
55. Visintin, A., A. Mazzoni, J. A. Spitzer, and D. M. Segal. 2001. Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysacharide sensitivity to Toll-like receptor 4. Proc. Natl. Acad. Sci. 98:12156-12161.
56. Winter, A. J., G. G. Schurig, S. M. Boyle, N. Sriranganathan, J. S. Bevins, F. M. Enright, P. H. Elzer, and J. D. Kope. 1996. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4. Am. J. Vet. Res. 57:677-683.
57. Yoshimura, A., E. Lien, R. R. Ingalls, E. Tuomanen, R. Dziarski, and D. T. Golenbock. 1999. Cutting edge: recognition of gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163:1-5.
58. Young, E. J. 1983. Human brucellosis. Rev. Infect. Dis. 5:821-842.
59. Zaitseva, M., H. Golding, J. Manischewitz, D. Webb, and B. Golding. 1996. Brucella abortus as a potential vaccine candidate: induction of interleukin-12 secretion and enhanced B7.1 and B7.2 and intercellular adhesion molecule 1 surface expression in elutriated human monocytes stimulated by heat-inactivated B. abortus. Infect. Immun. 64:3109-3119.
60. Zaitseva, M., L. R. King, J. Manischewitz, M. Dougan, L. Stevan, H. Golding, and B. Golding. 2001. Human peripheral blood T cells, monocytes, and macrophages secrete macrophage inflammatory proteins 1a and 1b following stimulation with heat-inactivated Brucella abortus. Infect. Immun. 69:3817-3826.
61. Zhan, Y., and C. Cheers. 1998. Control of IL-12 and IFN-γ production in response to live and dead bacteria by TNF and other factors. J. Immunol. 161:1447-1453.
62. Zinkernagel, R. M. 1974. Restriction by H-2 gene complex of transfer of cell-mediated immunity to Listeria monocytogenes. Nature 251:230-233.